Measles
DSQ Alert® Measles and RNase P Analyte Specific Reagents
As measles activity rises, molecular laboratories need flexible assay development options.
According to the Centers for Disease Control and Prevention, 2,281** confirmed measles cases were reported in 2025 compared with 285 cases in 2024, with outbreak-associated transmission continuing into 2026.
Unlike traditional multi-target approaches, this product suite utilizes a single PCR amplicon enhanced by Super I® nucleoside analogue chemistry, enabling shorter primer designs and stronger hybridization performance.
Proprietary Chemistry Designed for Target Discrimination
Designed to support molecular laboratories developing real-time PCR workflows for measles detection and vaccine strain discrimination, DSQ Alert® Measles and RNase P Analyte Specific Reagents combine proprietary chemistry with flexible workflow compatibility across validated open-channel platforms.
This design incorporates two proprietary probe chemistries to support target discrimination:
Built for Open Molecular Workflows
These reagents are optimized to support molecular labs to develop assays using real-time PCR on:
Ordering Information
Catalog # | Product Name |
M800845§
| DSQ Alert® Measles Primer Mix |
M800846§
| DSQ Alert® Measles Probe Mix |
M800847§
| DSQ Alert® RNase P Primer Mix |
M800848§
| DSQ Alert® RNase P Probe Mix |
§Analyte Specific Reagent. Analytical and performance characteristics are not established.
Why DSQ Chemistry Matters
The DSQ Alert® product line is built on proprietary DSQ probe chemistry engineered for broad-spectrum fluorescence quenching while preserving fluorophore compatibility and multiplexing flexibility.
This chemistry helps support stronger signal control across complex molecular designs.
** Measles Cases and Outbreaks (Centers for Disease Control and Prevention, US Department of Health and Human Services, 2026), https://www.cdc.gov/measles/data-research/index.html